Naloxegol
Movantik, Moventig (naloxegol) is a small molecule pharmaceutical. Naloxegol was first approved as Movantik on 2014-09-16. It is used to treat constipation in the USA. It has been approved in Europe to treat constipation and opioid-related disorders. Movantik's patents are valid until 2032-04-02 (FDA).
| Trade Name | Moventig |
|---|---|
| Common Name | Naloxegol |
| Indication | constipation, opioid-related disorders |
| Drug Class | Narcotic agonists/antagonists (normorphine type) |
